This talk will address common questions asked about patients with chronic kidney disease (CKD). What is a good blood pressure target for my patient? How should I use ACE-inhibitors and angiotensin receptor blockers (ARBs) in CKD? Or evaluate for secondary hypertension? What about new treatments like sodium bicarbonate and SGLT2 inhibitors? As well as answering these questions, the faculty will discuss the goals of the executive order from the Department of Health and Human Services signed in July 2019: reducing the risk of kidney failure, improving access and quality of person-centered treatment options, and increasing access to transplants.

Chronic kidney disease stage III represents significant renal insufficiency and carries an increased risk of mortality and morbidity. The talk will discuss the determination of CKD categories, their clinical implications, and appropriate testing and monitoring. Participants will receive an in-depth look at outcomes and strategies for preventing progression of renal insufficiency and review the appropriate time for consultation with a renal specialist.

Chronic kidney disease is common, yet many clinicians find it intimidating to manage. This session will give you the tools that you need to identify renal disease, recognize which patients are at risk for a decline in renal function, and practice the components of care.

Get your questions answered by expert faculty in Nephrology. You ask: we listen. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice.

Diabetic kidney disease is expected to surpass all other diabetes-related complications in morbidity and mortality. In this session, faculty will review current data on the renoprotective properties of SGLT2 inhibitors and explain the guideline recommendations for their use in patients with type 2 diabetes and kidney disease. *Please note that any data, indications and guidelines presented in this activity are current as of the original recording on 12/4/2019, and they are subject to change as new information is published.

Get your questions answered by expert faculty in Nephrology. You ask: we listen. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020, and they are subject to change as new information is published.

In this interactive case-based lecture, the faculty will answer the question “what is kidney disease?” and identify the common tests used to diagnose this often-silent disease. Additional slides will be devoted to interpreting urinalysis. The faculty will discuss diabetic kidney disease (DKD), the leading cause of chronic kidney disease (CKD), and how to manage it. The management portion of this lecture will emphasize the importance of renin-angiotensin aldosterone system (RAAS) inhibition and hypoglycemic agents in slowing the progression of CKD. You will receive an overview of common medications that require additional monitoring and learn more about renal replacement therapy in patients with comorbid diseases. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020 and they are subject to change as new information is published.